- Home
- PROF
as 11-26-2025 2:27pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | MISSISSAUGA |
| Market Cap: | 179.7M | IPO Year: | N/A |
| Target Price: | $11.00 | AVG Volume (30 days): | 91.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.76 - $8.75 | Next Earning Date: | 11-13-2025 |
| Revenue: | $14,297,000 | Revenue Growth: | 67.94% |
| Revenue Growth (this year): | 60.07% | Revenue Growth (next year): | 120.03% |
Latest Profound Medical Corp. News
PROF Breaking Stock News: Dive into PROF Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
Profound Medical (PROF) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
8 days ago
Wall Street Analysts Believe Profound Medical (PROF) Could Rally 97.59%: Here's is How to Trade
GlobeNewswire
9 days ago
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Zacks
14 days ago
Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates
MT Newswires
14 days ago
Profound Medical's Third-Quarter Loss Narrows on an 87% Rise in Revenue
GlobeNewswire
14 days ago
Profound Medical Reports Strong Third Quarter 2025 Financial Results
MT Newswires
15 days ago
Profound Medical Expands Access to TULSA-PRO in Australia, New Zealand Through Getz Healthcare Deal
GlobeNewswire
15 days ago
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
Compare PROF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.